These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 7933581

  • 21. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.
    Falk RJ, Jennette JC.
    N Engl J Med; 1988 Jun 23; 318(25):1651-7. PubMed ID: 2453802
    [Abstract] [Full Text] [Related]

  • 22. Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils.
    Hu N, Westra J, Huitema MG, Bijl M, Brouwer E, Stegeman CA, Heeringa P, Limburg PC, Kallenberg CG.
    Arthritis Rheum; 2009 May 23; 60(5):1548-57. PubMed ID: 19404956
    [Abstract] [Full Text] [Related]

  • 23. 'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis.
    Gross WL, Csernok E, Flesch BK.
    J Autoimmun; 1993 Apr 23; 6(2):171-84. PubMed ID: 8388690
    [Abstract] [Full Text] [Related]

  • 24. [ANCA-associated vasculitis (Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis). 1. Systemic aspects, pathogenesis and clinical aspects].
    Gross WL, Reinhold-Keller E.
    Z Rheumatol; 1995 Apr 23; 54(5):279-90. PubMed ID: 8578884
    [Abstract] [Full Text] [Related]

  • 25. Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis.
    Malenica B, Rudolf M, Kozmar A.
    Acta Dermatovenerol Croat; 2004 Apr 23; 12(4):294-313. PubMed ID: 15588565
    [Abstract] [Full Text] [Related]

  • 26. Anti-neutrophil cytoplasmic antibodies: a new class of autoantibodies in glomerulonephritis, vasculitis and other inflammatory disorders.
    Tervaert JW, Stegeman CA, Brouwer E, Mulder AH, Limburg PC, Kallenberg CG.
    Neth J Med; 1994 Dec 23; 45(6):262-72. PubMed ID: 7838242
    [Abstract] [Full Text] [Related]

  • 27. Detection of anti-neutrophil cytoplasmic antibodies by immunoprecipitation.
    Lucena-Fernandes F, Dalpé G, Dagenais P, Richard C, Calvert R, Boire G, Ménard HA.
    Clin Invest Med; 1995 Jun 23; 18(3):153-62. PubMed ID: 7554581
    [Abstract] [Full Text] [Related]

  • 28. Antineutrophil antibodies in vasculitis.
    Savage CO, Lockwood CM.
    Adv Nephrol Necker Hosp; 1990 Jun 23; 19():225-36. PubMed ID: 2105580
    [Abstract] [Full Text] [Related]

  • 29. [Antineutrophil cytoplasmic antibodies as marker and follow-up parameter of vasculitis and glomerulonephritis].
    Wüthrich RP.
    Praxis (Bern 1994); 1994 Oct 25; 83(43):1202-6. PubMed ID: 7973270
    [Abstract] [Full Text] [Related]

  • 30. Autoantibodies and target antigens in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.
    Savige JA, Chang L, Wilson D, Buchanan RR.
    Rheumatol Int; 1996 Oct 25; 16(3):109-14. PubMed ID: 8893375
    [Abstract] [Full Text] [Related]

  • 31. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D.
    Am J Kidney Dis; 2003 Mar 25; 41(3):539-49. PubMed ID: 12612976
    [Abstract] [Full Text] [Related]

  • 32. Diverse target antigens recognized by circulating antibodies in anti-neutrophil cytoplasm antibody-associated renal vasculitides.
    Savige JA, Gallicchio M, Georgiou T, Davies DJ.
    Clin Exp Immunol; 1990 Nov 25; 82(2):238-43. PubMed ID: 1978702
    [Abstract] [Full Text] [Related]

  • 33. Anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies.
    Dillon MJ, Tizard EJ.
    Pediatr Nephrol; 1991 Mar 25; 5(2):256-9. PubMed ID: 2031846
    [Abstract] [Full Text] [Related]

  • 34. Immunodiagnostic aspects of autoantibodies against myeloperoxidase.
    Ulmer M, Rautmann A, Gross WL.
    Clin Nephrol; 1992 Apr 25; 37(4):161-8. PubMed ID: 1316247
    [Abstract] [Full Text] [Related]

  • 35. [Anti-neutrophil cytoplasmic antibodies (ANCA): major progress in the diagnosis of vasculitis].
    Goldman M, Servais C, Lambermont M, Tielemans C, Lambrechts A, Mascart-Lemone F, Dupont E.
    Rev Med Brux; 1992 Nov 25; 13(9):333-6. PubMed ID: 1361072
    [Abstract] [Full Text] [Related]

  • 36. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.
    Gross WL, Schmitt WH, Csernok E.
    Clin Exp Immunol; 1993 Jan 25; 91(1):1-12. PubMed ID: 8419069
    [Abstract] [Full Text] [Related]

  • 37. Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis.
    Tervaert JW, Limburg PC, Elema JD, Huitema MG, Horst G, The TH, Kallenberg CG.
    Am J Med; 1991 Jul 25; 91(1):59-66. PubMed ID: 1677531
    [Abstract] [Full Text] [Related]

  • 38. Antineutrophil cytoplasmic autoantibodies: immunobiological aspects.
    Gross WL, Csernok E, Schmitt WH.
    Klin Wochenschr; 1991 Sep 03; 69(13):558-66. PubMed ID: 1721666
    [Abstract] [Full Text] [Related]

  • 39. Anti-neutrophil cytoplasm antibodies (ANCA).
    Savige JA, Davies DJ.
    Aust N Z J Med; 1990 Jun 03; 20(3):271-4. PubMed ID: 2196872
    [Abstract] [Full Text] [Related]

  • 40. Antineutrophil cytoplasmic autoantibody--associated glomerulonephritis: potentially reversible disease.
    Wen SF.
    J Formos Med Assoc; 1994 Jul 03; 93(7):545-61. PubMed ID: 7866052
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.